Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phentermine in Preoperative Bariatric Surgery
NCT03849729Phase 4Completed
- Sponsor
- Hospital Juárez de México
- Start
- Mar 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and non-alcoholic fatty liver disease (NAFLD) comparing Phentermine with Placebo (2 arms). Primary endpoints: Number of participants with Intrahepatic fat at 6 weeks and Fat tissue at 6 weeks. Started Mar 2018; status: completed.
02
Drugs
phentermine
03
Conditions
obesitynon-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT03849729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849729.